- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 834
WorkBoard chalks up $23m in series B
Workday joined existing investor Microsoft in a round that will support the development of WorkBoard's enterprise planning software, taking its total funding to $35m.
Mar 26, 2019HoneyBook folds in $28m
The Citi Ventures-led round increased the total raised by the freelance business and financial planning service to $60m in the past five years.
Mar 26, 2019IPlytics dives into funding
TU Berlin spinout IPlytics has collected several million dollars from investors including High-Tech Gründerfonds to expand into the US, South Korea and Japan.
Mar 26, 2019MX Federation adds Bertelsmann to series C1 mix
GLP-backed BitRock Capital has led an eight-figure dollar round for the digital wealth management platform that also featured existing backer BAI.
Mar 26, 2019Hesus ascends with corporate funding
Bouygues Construction and Suez Group have both contributed to an $11.3m round that will fund the construction waste removal service's European expansion.
Mar 26, 2019Meyer Burger manufactures Oxford PV stake
Meyer Burger picked up an 18% share in solar film manufacturing spinout Oxford PV, following a recent $41m first series D close for the spinout.
Mar 25, 2019Delhivery picks up another $413m
Three weeks after reports suggested SoftBank Vision Fund had led a $395m series F round for e-commerce delivery service Delhivery, the size has been confirmed as $413m.
Mar 25, 2019Ke collects Tencent on its way to $800m
The Lianjia spinoff is currently raising $800m in a series D round that will be led by Tencent, and which looks likely to be its first external funding.
Mar 25, 2019Carbon Engineering unearths $68m
Chevron, Occidental Petroleum, BHP and Bethel Lands all invested in a round that will fund further testing of Carbon Enginnering's carbon capture technology.
Mar 25, 2019Pfizer visits Vivet with $51m
Pharmaceutical firm Pfizer has acquired a 15% stake in the gene therapy developer along with an exclusive option to fully buy the Novartis-backed company.
Mar 25, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


